David Anz - Concepedia

Author

David Anz

Ludwig-Maximilians-Universität München ORCID

Also Known As

Anz David, Anz, David, D Anz, D. Anz, David Anz

146

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Center for Integrated Protein Science Munich LMU Klinikum Technical University of Munich University of Bonn

About

David Anz is an author at Ludwig-Maximilians-Universität München specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.2K
2	Cell Biology	13	13	1.2K
3	Allergy	2	2	180
4	Engineering	1	1	30
5	Biomedical Engineering	1	1	30

David Anz

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions Yvonne Dombrowski, Mark Perić, Sarah Koglin, Science Translational Medicine	2011	417
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma Hendrik Poeck, Robert Besch, Cornelius Maihoefer, Nature Medicine MedicineMelanomaGene SilencingCancer BiologyCell Biology	2008	383
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes Moritz Rapp, Maximilian W. M. Wintergerst, Wolfgang G. Kunz, The Journal of Experimental Medicine	2019	248
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice Christine Zoglmeier, Helen Bauer, Daniel Nörenberg, Clinical Cancer Research	2011	237
Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing Florian Haasters, Wolf Christian Prall, David Anz, Journal of Anatomy	2009	175
Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity Carole Bourquin, David Anz, Klaus Zwiorek, The Journal of Immunology Cpg-loaded NanoparticlesImmunologyImmunoeditingImmune SystemImmunotherapy	2008	151
CD103 is a hallmark of tumor‐infiltrating regulatory T cells David Anz, Wolfgang P. Mueller, Michaela Golić, International Journal of Cancer	2011	111
ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells Peter Duewell, Ulrich Kisser, Klaus Heckelsmiller, The Journal of Immunology	2011	107
Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes Andrea Ablasser, Hendrik Poeck, David Anz, The Journal of Immunology Rna RecognitionImmunologyImmune RegulationImmunologic MechanismInnate Immunity	2009	101
Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells Gabriela M. Wiedemann, Maximilian M. L. Knott, Viola Katharina Vetter, OncoImmunology	2016	98

Page 1